Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Genitourinary 1

Conditions

Sarcoma, Clear Cell 2Sarcoma 2Neurofibrosarcoma 2Nerve Sheath Neoplasms 2Liposarcoma 2Histiocytoma, Angiomatoid Fibrous 2Granuloma, Plasma Cell 2Fibrosarcoma 2Dermatofibrosarcoma 2Chondrosarcoma, Extraskeletal Myxoid 2Vascular Neoplasms 1Solitary Fibrous Tumors 1Smooth Muscle Tumor 1Sarcoma, Synovial 1Sarcoma, Alveolar Soft Part 1Perivascular Epithelioid Cell Neoplasms 1Osteosarcoma 1Neoplasms, Plasma Cell 1Neoplasms, Adipose Tissue 1Myoepithelioma 1Liposarcoma, Myxoid 1Leiomyosarcoma 1Histiocytoma, Malignant Fibrous 1Hemangiosarcoma 1Hemangioendothelioma, Epithelioid 1Granular Cell Tumor 1Glomus Tumor 1Disorders of Sex Development 1Chondrosarcoma, Mesenchymal 1Carcinoma, Renal Cell 1

Interventions

Dexamethasone 111Cyclophosphamide 99Melphalan 91Bortezomib 69Peripheral Blood Stem Cell Transplantation 64Lenalidomide 58fludarabine phosphate 56Busulfan 54Filgrastim 50Tacrolimus 38Antilymphocyte Serum 38Thalidomide 36Radiotherapy 36Mycophenolic Acid 33fludarabine 28Cyclosporine 26Methotrexate 25Etoposide 22Calcium Dobesilate 22Whole-Body Irradiation 21Prednisone 21Methylprednisolone 20sargramostim 19pomalidomide 19Granulocyte Colony-Stimulating Factor 18carfilzomib 16daratumumab 15Cord Blood Stem Cell Transplantation 15Carmustine 14Rituximab 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms, Plasma Cell × pazopanib × Plasma cell × Clear all
NCT00256880 2017-01-18

Pazopanib (GW786034) In Subjects With Relapsed Or Refractory Multiple Myeloma

GlaxoSmithKline

Phase 2 Completed
100 enrolled
GenitourinaryPlasma cell

Carcinoma, Renal Cell, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡